Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 10,924 | 10,241 | 9,392 | 10,771 | 7,777 |
| Operating Income | -10,924 | -10,241 | -9,392 | -10,771 | -7,777 |
| Interest Expense | 49 | 36 | 2 | 1 | 714 |
| Other Income | 3,744 | -1,550 | 445 | 114 | 932 |
| Pre-tax Income | -7,229 | -11,827 | -8,949 | -10,658 | -7,559 |
| Net Income Continuous | -7,229 | -11,827 | -8,949 | -10,658 | -7,559 |
| Net Income | $-7,229 | $-11,827 | $-8,949 | $-10,658 | $-7,559 |
| EPS Basic Total Ops | -0.64 | -1.15 | 21.69 | -1.27 | -2.61 |
| EPS Basic Continuous Ops | -0.64 | -1.15 | 21.70 | -1.27 | -2.61 |
| EPS Diluted Total Ops | -0.64 | -1.15 | 21.69 | -1.27 | -2.61 |
| EPS Diluted Continuous Ops | -0.64 | -1.15 | 21.70 | -1.27 | -2.61 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -1.15 | -3.77 | N/A | N/A |
| EBITDA(a) | $-10,631 | $-9,951 | $-9,106 | $-10,498 | $-7,276 |